Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 September 2019 | Story Xolisa Mnukwa | Photo Xolisa Mnukwa
Shannon Arnold and Samkezi Mbalane
Shannon Arnold (left) and Samkezi Mbalane (right), the 2019 UFS recipients of the prestigious International Abe Bailey Travel Bursary.

The University of the Free State (UFS) has selected MPhil (African Studies) student and self-proclaimed ‘radical feminist’, Shannon Arnold, and former Golden Key UFS Qwaqwa Campus Chapter President and Political Studies and Governance honours student, Samkezi Mbalane, to represent the institution this year on the Abe Bailey Travel Bursary tour

The Abe Bailey Travel Bursary is a leadership-development programme that honours and targets university students or junior lecturers with a strong academic background, and who have shown exceptional qualities of leadership and service during their university careers as well as in a wider social context. Recipients of the bursary are expected to function as an integral part of a select and highly skilled group of individuals who will be embarking on a five-stage tour in December, starting in Cape Town (South Africa) and finishing in London (United Kingdom).

“Success comes from a feeling of satisfaction in what I have done for myself” – Shannon Arnold

Shannon Arnold, who is originally from Grahamstown, Eastern Cape, completed her undergraduate and honours studies in Political and International Studies and English Literature at Rhodes University. She moved to the UFS and is currently completing her transdisciplinary MPhil in African Studies, focused on Peace and Conflict in Post-conflict African Societies from a gendered perspective. 

“Moving to the Free State was an interesting cultural transition,” Arnold remarked. 
She further expressed how “pleasantly enlightened” she was by the UFS’s active and direct approach to transformation, and how it allowed her to spearhead and coordinate crucial student-movement initiatives such as the total shutdown protest which saw women and students march from the UFS Bloemfontein Campus to the Supreme Court of Appeal in 2018. Arnold believes that her passion, work, and experiences with community and service-based organisations against South Africa’s plight of gender-based violence has branded her a leader and qualified her for becoming an ‘Abe’.

Arnold grew up in a community-minded family and has thus been aligned with politics from a very young age. She is inspired by the thought of manifesting a reality where women in South Africa are able to pursue their own choices. She looks forward to exposing herself to foreign cultures on the tour to the UK, engaging with people who have like-minded convictions. 

“The desire and compassion to motivate and uplift others is what inspires me.”  – Samkezi Mbalane

Eastern Cape, Mount Fletcher-born Samkezi Mbalane, who graduated from the UFS with his undergraduate degree in Political Studies and Governance (Cum Laude), labels his life journey as ‘very difficult, yet fascinating’. 

Having been raised by a struggling single mother, he reflects on being dependant on other people in his immediate community for basic needs. He lived in a foster home for three years (Grade 10 to 12) as a means of survival. Mbalane explained that such experiences motivated him to pursue a career in politics, as he dreams of playing a pivotal role in the creation and implementation of South African governmental policies that will one day effectively benefit the poor.

Mbalane believes his claim to leadership came through ‘hard work and persistence’. He has served in various leadership positions, including President of the Golden Key Society UFS Qwaqwa Campus Chapter, Prime at Steve Biko Residence, active member of the Institute for Reconciliation and Social Justice, Enactus, and the Secretary General of the Student Parliament. Mbalane deemed being selected an ‘Abe’ as an “iconic opportunity for all aspirant leaders in South Africa.” 

He looks forward to working with people from different cultural backgrounds and career fields, but mostly, to seeing the world outside South Africa from a unique perspective.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept